COMMUNIQUÉS West-GlobeNewswire

-
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/12/2024 -
UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
13/12/2024 -
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
13/12/2024 -
L’édition 2024 du congrès FAAM-EUROBAT s’achève sur des avancées révolutionnaires en matière de recherche sur les allergies alimentaires et l’anaphylaxie
13/12/2024 -
CannExpo 2025: Igniting the Cannabis Lifestyle in Toronto
13/12/2024 -
Protest as MPPs come to Stratford on pre-budget tour: Local citizens angry at Ford government for underfunding, privatizing & destroying our public health care plan to make their voices heard
13/12/2024 -
Scilex Holding Company Announces Closing of $17 Million Registered Direct Offering
13/12/2024 -
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
13/12/2024 -
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
13/12/2024 -
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
13/12/2024 -
SPR® Therapeutics Recognized as the Fastest Growing Private Company in Northeast Ohio as Part of the Crain’s Fast 50 List
13/12/2024 -
Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card
13/12/2024 -
PharmAla Announces Private Placement
13/12/2024 -
Amarin Appoints Peter Fishman Chief Financial Officer
13/12/2024 -
QHSLab (OTCQB:USAQ) and South Dakota State University Celebrate NSF Invitation to Submit STTR Application for AIR-GUIDDE Technology
13/12/2024 -
Medicenna Presents Preclinical Data on MDNA11 as First Step to Shrink Tumors Before Surgery and Prevent Metastasis at the 2024 San Antonio Breast Cancer Symposium (SABCS)
13/12/2024 -
Sienna Announces December Dividend
13/12/2024 -
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/12/2024 -
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
13/12/2024
Pages